Evidence map›Paper›PMID 21538436›Full record

ArticleHepatology (Baltimore, Md.)2011

Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis.

Henriette E Meyer zu Schwabedissen, Joseph A Ware, David Finkelstein, Amarjit S Chaudhry, Sara Mansell, Matilde Leon-Ponte, Stephen C Strom, Hani Zaher, Ute I Schwarz, David J Freeman and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. New insights into thyroid hormone action.Pharmacology & therapeutics · 2017
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Henriette E Meyer zu SchwabedissenDivision of Clinical Pharmacology, Department of Medicine, The University of Western Ontario, London, ON, Canada.
Joseph A Ware
David Finkelstein
Amarjit S Chaudhry
Sara Mansell
Matilde Leon-Ponte
Stephen C Strom
Hani Zaher
Ute I Schwarz
David J Freeman
Erin G Schuetz
Rommel G Tirona
Richard B Kim
Western University · CASt. Jude Children's Research Hospital · USPfizer (United States) · USUniversity of Pittsburgh · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Whole GenomeU01GM061393 · NIGMS · UNIVERSITY OF CHICAGO · PI RATAIN, MARK J · 2000 to 2014
$39.0M
PAARK4Kids-Pharmacogenomics of Anticancer Agents Research in ChildrenU01GM092666 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI RELLING, MARY V · 2010 to 2014
$8.9M
Genetic Predictors of Human Liver CYP Expression & ActivityR01GM094418 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SCHUETZ, ERIN G · 2010 to 2013
$1.4M
CIHR MOP 89753NCI NIH HHS P30 CA021765NCI NIH HHS P30 CA21765NIGMS NIH HHS R01 GM094418NIGMS NIH HHS R01GM094418NIGMS NIH HHS U01 GM061393NIGMS NIH HHS U01 GM092666
6 · The paper itself

Abstract

unlabelledThe role of organic anion transporting polypeptides (OATPs), particularly the members of OATP1B subfamily, in hepatocellular handling of endogenous and exogenous compounds is an important and emerging area of research. Using a mouse model lacking Slco1b2, the murine ortholog of the OATP1B subfamily, we have demonstrated previously that genetic ablation causes reduced hepatic clearance capacity for substrates. In this study, we focused on the physiological function of the hepatic OATP1B transporters. First, we studied the influence of the Oatp1b2 deletion on bile acid (BA) metabolism, showing that lack of the transporter results in a significantly reduced expression of Cyp7a1, the key enzyme of BA synthesis, resulting in elevated cholesterol levels after high dietary fat challenge. Furthermore, Slco1b2-/- mice exhibited delayed clearance after oral glucose challenge resulting from reduced hepatic glucose uptake. In addition to increased hepatic glycogen content, Slco1b2-/- mice exhibited reduced glucose output after pyruvate challenge. This is in accordance with reduced hepatic expression of phosphoenolpyruvate carboxykinase (PEPCK) in knockout mice. We show that this phenotype is due to the loss of liver-specific Oatp1b2-mediated hepatocellular thyroid hormone entry, which then leads to reduced transcriptional activation of target genes of hepatic thyroid hormone receptor (TR), including Cyp7a1 and Pepck but also Dio1 and Glut2. Importantly, we assessed human relevance using a cohort of archived human livers in which OATP1B1 expression was noted to be highly associated with TR target genes, especially for glucose facilitating transporter 2 (GLUT2). Furthermore, GLUT2 expression was significantly decreased in livers harboring a common genetic polymorphism in SLCO1B1.

conclusionOur findings reveal that OATP1B-mediated hepatic thyroid hormone entry is a key determinant of cholesterol and glucose homeostasis.

Indexed as

HomeostasisAnimalsCholesterolGlucoseHumansMiceOrganic Anion TransportersReceptors, Thyroid HormoneCholesterolGlucoseOrganic Anion TransportersReceptors, Thyroid Hormone

Identifiers

PMID21538436
PMCPMC3164486
OpenAlexW2005153574

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.